Back
SELLAS Life Sciences Group 10K Form
Sell
37
SLS
SELLAS Life Sciences Group
Last Price:
1.17
Seasonality Move:
1.69%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive SLS News And Ratings
See the #1 stock for the next 7 days that we like better than SLS
SLS Financial Statistics
Sales & Book Value
Annual Sales: | $1M |
---|---|
Cash Flow: | $-9.68M |
Price / Cash Flow: | 0 |
Annual Sales: | $0.05 |
Price / Book: | 27.05 |
Profitability
EPS (TTM): | -0.92000 |
---|---|
Net Income (TTM): | $-34.44M |
Gross Margin: | $0 |
Return on Equity: | 0% |
Return on Assets: | 0% |
SELLAS Life Sciences Group Earnings Forecast
Key SELLAS Life Sciences Group Financial Ratios
- The Selling, General & Administrative Expenses for SLS have been equal to 1,258.20% of Gross Profit Margin.
- The Interest Expense is -0.98% of Operating Income.
- Per Share Earnings over the last 18 years have been positive in 10 years.
SELLAS Life Sciences Group Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | SLS |
CUSIP: | 81642T |
Website: | sellaslifesciences.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 0 |
Quick Ratio: | 0 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
SLS Technical Analysis vs Fundamental Analysis
Sell
37
SELLAS Life Sciences Group (SLS)
is a Sell
Is SELLAS Life Sciences Group a Buy or a Sell?
-
SELLAS Life Sciences Group stock is rated a Sell
The current SELLAS Life Sciences Group [SLS] share price is $1.20. The Score for SLS is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.